I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 97 filers reported holding I MAB in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,477 | -97.5% | 38,998 | -94.2% | 0.00% | – |
| Q2 2023 | $2,027,884 | -14.0% | 678,222 | -0.5% | 0.00% | – |
| Q1 2023 | $2,357,440 | -33.0% | 681,341 | -19.0% | 0.00% | – |
| Q4 2022 | $3,516,993 | +1.2% | 841,386 | -2.9% | 0.00% | – |
| Q3 2022 | $3,476,000 | -68.0% | 866,739 | -9.8% | 0.00% | -100.0% |
| Q2 2022 | $10,860,000 | -23.6% | 961,004 | +9.8% | 0.00% | 0.0% |
| Q1 2022 | $14,213,000 | -60.9% | 875,229 | +14.1% | 0.00% | -75.0% |
| Q4 2021 | $36,359,000 | -8.5% | 767,233 | +39.9% | 0.00% | 0.0% |
| Q3 2021 | $39,758,000 | -11.4% | 548,465 | +2.7% | 0.00% | -20.0% |
| Q2 2021 | $44,854,000 | +81.1% | 534,295 | +4.6% | 0.01% | +66.7% |
| Q1 2021 | $24,764,000 | +411.9% | 510,925 | +397.9% | 0.00% | +200.0% |
| Q4 2020 | $4,838,000 | +107.2% | 102,609 | +106.7% | 0.00% | – |
| Q3 2020 | $2,335,000 | – | 49,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $293,220 | 0.32% |
| HHLR ADVISORS, LTD. | 6,909,220 | $9,120,170 | 0.20% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $409,859 | 0.14% |
| Maso Capital Partners Ltd | 100,000 | $132 | 0.07% |
| Diametric Capital, LP | 122,953 | $162,297 | 0.07% |
| Artal Group S.A. | 850,000 | $1,122 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 195,546 | $258 | 0.02% |
| Headlands Technologies LLC | 7,394 | $9,760 | 0.01% |
| Temasek Holdings (Private) Ltd | 566,650 | $747,978 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 39,471 | $52,102 | 0.00% |